Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes

被引：21

作者：

Invernizzi, R ^{[1
]}

Travaglino, E ^{[1
]}

De Amici, M ^{[1
]}

Brugnatelli, S ^{[1
]}

Ramajoli, I ^{[1
]}

Rovati, B ^{[1
]}

Benatti, C ^{[1
]}

Ascari, E ^{[1
]}

机构：

[1] Univ Pavia, IRCCS, Policlin San Matteo, Dept Pediat, I-27100 Pavia, Italy

来源：

LEUKEMIA RESEARCH | 2005年 / 29卷 / 06期

关键词：

thalidomide; myelodysplastic syndromes; apoptosis; angiogenic cytokines; matrix metalloproteinases; lymphocyte subsets;

D O I：

10.1016/j.leukres.2004.11.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We treated with thalidomide seven patients with primary MDS and observed reduction of the transfusion requirement in three cases and reduction of bone marrow blasts in one case. The apoptotic rate of bone marrow cells diminished significantly from a mean of 43.8% to a mean of 17.5%, whereas the proliferative activity did not change. Plasma TNF-alpha, bFGF, IL-1 beta levels decreased variably, whereas VEGF levels tended to increase. Matrix metalloproteinases 2 and 9 expression decreased in bone marrow cells of responders. A reduction of CD4 cells and an increase of NK cells was observed in the peripheral blood. Thus, thalidomide may produce a fairly good hematological improvement in erythroid series in MDS. with complex biological mechanisms. (c) 2004 Elsevier Ltd. All rights reserved.

引用

页码：641 / 647

页数：7

共 50 条

[1] Thalidomide for the treatment of patients with myelodysplastic syndromes
Strupp, C
Germing, U
Aivado, M
Misgeld, E
Haas, R
Gattermann, N
LEUKEMIA, 2002, 16 (01) : 1 - 6
[2] Thalidomide for the treatment of patients with myelodysplastic syndromes
C Strupp
U Germing
M Aivado
E Misgeld
R Haas
N Gattermann
Leukemia, 2002, 16 : 1 - 6
[3] Autophagy level of bone marrow mononuclear cells in patients with myelodysplastic syndromes
郭利芳
ChinaMedicalAbstracts(InternalMedicine), 2016, 33 (01) : 54 - 54
[4] Ultrastructural observations on bone marrow cells of 26 patients with myelodysplastic syndromes
Cohen, AM
Alexandrova, S
Bessler, H
Mittelman, M
Cycowitz, Z
Djaldetti, M
LEUKEMIA & LYMPHOMA, 1997, 27 (1-2) : 165 - 172
[5] Treatment of myelodysplastic syndromes with azacitidine and thalidomide
Kenealy, M. K.
Seymour, J. F.
LEUKEMIA RESEARCH, 2007, 31 : S7 - S8
[6] Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes
Schildgen, Verena
Luesebrink, Jessica
Tillmann, Ramona Liza
Wulfert, Michael
Gattermann, Norbert
Schildgen, Oliver
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2011, 5 (04) : 221 - 222
[7] Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability
Florian Nolte
Michelle Giehl
Wiltrud Haass
Verena Nowak
Christiane Schumann
Daniel Nowak
Maximillian Mossner
Henning D. Popp
Torsten J. Schulze
Stefan Klein
Wolfgang Seifarth
Wolf-Karsten Hofmann
Alice Fabarius
Annals of Hematology, 2013, 92 : 1325 - 1333
[8] VCAM-1 Expression on Bone Marrow Stromal Cells from Patients with Myelodysplastic Syndromes
Lubkova, O. N.
Tzvetaeva, N. V.
Momotyuk, K. S.
Belkin, V. M.
Manakova, T. E.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 151 (01) : 13 - 15
[9] Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability
Nolte, Florian
Giehl, Michelle
Haass, Wiltrud
Nowak, Verena
Schumann, Christiane
Nowak, Daniel
Mossner, Maximillian
Popp, Henning D.
Schulze, Torsten J.
Klein, Stefan
Seifarth, Wolfgang
Hofmann, Wolf-Karsten
Fabarius, Alice
ANNALS OF HEMATOLOGY, 2013, 92 (10) : 1325 - 1333
[10] Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes
Zhao, Zhi-Gang
Xu, Wen
Yu, Hai-Peng
Fang, Bing-Ling
Wu, Shu-Hong
Li, Fang
Li, Wei-Min
Li, Qiu-Bai
Chen, Zhi-Chao
Zou, Ping
CANCER LETTERS, 2012, 317 (02) : 136 - 143

← 1 2 3 4 5 →